InsidersTradesSigma
Follow the PHARMANUTRA PR share price and the full management transaction log of the company, a publicly traded company based in Italy. Shares trade on the IT market, under the authority of Consob. Operating in the Health Care sector, PHARMANUTRA PR has logged 1 reports. Market capitalisation: €804.3m. The latest transaction was disclosed on 24 July 2024 (Other). Every trade is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,315 of 28,856 companies
62.0
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2024
About PHARMANUTRA PR
PHARMANUTRA PR is a company operating in the health and pharmaceutical sector, listed on the XMIL market. It focuses on the development and marketing of nutraceutical and pharmaceutical products.